Considerations on the Transformation and Application of New Chinese MedicineDrug in Medical Institutions under the System of Production-study-research

doi:10.16153/j.1002-7777.2024.03.002

Luo Lina, Chen Gengxin

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (3) : 250-256.

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (3) : 250-256. DOI: 10.16153/j.1002-7777.2024.03.002

Supervision Administration

Considerations on the Transformation and Application of New Chinese MedicineDrug in Medical Institutions under the System of Production-study-research

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 38(3): 250-256 https://doi.org/10.16153/j.1002-7777.2024.03.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

Accesses

Citation

Detail

Sections

Recommended

Please choose a citation manager

Content to export